Obstetric and Gynecologic Imaging

What Is the Next Imaging Step for Increased Fetal Nuchal Translucency?

·
What Is the Next Imaging Step for Increased Fetal Nuchal Translucency?

A 29-year-old primigravida presents for her routine first-trimester screening ultrasound at 12 weeks and 4 days of gestation. The sonographer obtains excellent images, but the nuchal translucency (NT) measures 4.1 mm, which is significantly above the 95th percentile for the fetal crown-rump length. The patient is understandably anxious, and you are now faced with determining the appropriate next steps in the diagnostic workup. What is the most appropriate imaging study to order next to evaluate the fetus and guide patient counseling? According to the American College of Radiology (ACR) Appropriateness Criteria, a dedicated fetal echocardiogram is a key part of the subsequent evaluation and is rated Usually Appropriate.

Who Fits This Clinical Scenario for Increased Nuchal Translucency?

This clinical workflow is designed for a specific, well-defined patient presentation: a singleton pregnancy between 11 weeks 0 days and 13 weeks 6 days of gestation where the nuchal translucency measurement is increased. An “increased” measurement is typically defined as being greater than or equal to the 95th percentile for the specific crown-rump length (CRL) or, in some definitions, a fixed cutoff such as 3.0 mm or 3.5 mm. The key is that this is an abnormal finding on a screening ultrasound that necessitates a more detailed diagnostic evaluation.

This guidance does not apply to several similar-sounding but distinct clinical situations, which have their own evaluation pathways:

  • Routine NT Screening: This article is not for patients with a normal NT measurement undergoing routine first-trimester screening.
  • Increased NT in Dichorionic Twins: The workup for dizygotic or dichorionic-diamniotic twins with an increased NT in one or both fetuses involves different considerations for risk and management.
  • Increased NT in Monochorionic Twins: This scenario is particularly complex due to the shared circulation, which introduces risks like twin-twin transfusion syndrome (TTTS) and selective fetal growth restriction, requiring a specialized evaluation.

Correctly identifying that your patient has a singleton gestation with an isolated finding of increased NT is the critical first step to applying this workflow.

What Diagnoses Are You Working Up in This Scenario?

An increased nuchal translucency is a powerful but nonspecific marker, indicating an increased risk for a broad spectrum of fetal conditions. The subsequent imaging and genetic workup is designed to differentiate among these possibilities, which range from major chromosomal disorders to isolated structural defects, or even a transient finding in an ultimately healthy baby.

The primary diagnostic concern is chromosomal aneuploidy. Increased NT is strongly associated with conditions like Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), Trisomy 13 (Patau syndrome), and Monosomy X (Turner syndrome). The degree of NT thickening often correlates with the magnitude of risk for these conditions.

A second major consideration, and a key driver for the recommended imaging, is congenital heart disease (CHD). A thickened NT is one of the earliest and most significant prenatal markers for major structural cardiac defects, even in the absence of a chromosomal abnormality (i.e., in euploid fetuses). The proposed mechanism involves early hemodynamic changes or lymphatic abnormalities that manifest as fluid accumulation in the nuchal region.

Less commonly, increased NT can be a marker for a wide array of other structural anomalies or genetic syndromes. These can include skeletal dysplasias, congenital diaphragmatic hernia, omphalocele, and rare single-gene disorders like Noonan syndrome.

Finally, it is important to remember that an isolated, mildly increased NT can be a transient finding with a normal outcome. However, this is a diagnosis of exclusion that can only be made after a comprehensive anatomic and genetic evaluation has been completed and found to be normal.

Why Is Fetal Echocardiography the Recommended Study for This Presentation?

The ACR Appropriateness Criteria rate both `US pregnant uterus transabdominal` (for a detailed anatomic survey) and `US echocardiography fetal` as Usually Appropriate in this scenario. However, the specific recommendation for a fetal echocardiogram addresses the significantly elevated risk of congenital heart disease associated with increased NT. While a detailed first-trimester anatomic survey is crucial, a dedicated fetal echocardiogram provides a more focused and comprehensive evaluation of cardiac structures, function, and blood flow patterns.

The rationale for prioritizing a detailed cardiac assessment includes:

  • High Association with CHD: Increased NT is a primary indicator for underlying cardiac anomalies. A specialized fetal echocardiogram performed by an experienced operator can detect many major structural heart defects early in gestation, which is critical for parental counseling, delivery planning, and neonatal management.
  • Complementary to Anatomic Survey: The fetal echo does not replace the need for a full anatomic survey but rather enhances it by focusing on the organ system at highest risk. Often, these studies are performed in conjunction by a maternal-fetal medicine specialist or pediatric cardiologist.
  • Safety and Lack of Radiation: All recommended and potential imaging modalities in this workup are ultrasound-based. They involve no ionizing radiation (0 mSv), making them the safest approach for evaluating the fetus.

Two other studies are rated as May be appropriate:

  • US duplex Doppler pregnant uterus: This study assesses blood flow in vessels like the ductus venosus, umbilical artery, and uterine arteries. Abnormal flow patterns can add to the overall risk assessment for aneuploidy and adverse outcomes but do not directly diagnose structural cardiac defects. It is an adjunctive tool, not the primary diagnostic study for anatomy.
  • US pregnant uterus transvaginal: A transvaginal approach can sometimes offer higher-resolution images, especially in early gestation or in cases of challenging maternal body habitus. It may be used to supplement the transabdominal scan to better visualize specific structures but is not typically the primary modality for a complete fetal echo or anatomic survey.

What’s Next After Fetal Imaging? Downstream Workflow

The results of the detailed ultrasound and fetal echocardiogram are a critical branch point in the management pathway, which almost always involves genetic counseling and the offer of diagnostic testing.

  • If the Fetal Echo or Anatomic Survey Is Abnormal: The identification of a major structural anomaly (e.g., a ventricular septal defect, tetralogy of Fallot, or diaphragmatic hernia) provides a specific diagnosis. This finding dramatically increases the likelihood of an underlying genetic or chromosomal cause. The patient should be referred to a maternal-fetal medicine (MFM) specialist and other relevant subspecialists (like pediatric cardiology or surgery) for comprehensive counseling. Diagnostic genetic testing via chorionic villus sampling (CVS) or amniocentesis should be strongly recommended to obtain a definitive karyotype and/or microarray analysis.
  • If the Fetal Echo and Anatomic Survey Are Normal: This is a reassuring finding that significantly reduces the risk of a major structural defect. However, it does not eliminate the elevated risk of aneuploidy or other genetic syndromes. The patient should still undergo genetic counseling and be offered diagnostic testing (CVS or amniocentesis), as the risk conferred by the increased NT remains. Even with a normal karyotype, there is a residual increased risk for adverse pregnancy outcomes, and serial growth scans later in pregnancy may be warranted.
  • If the Study Is Indeterminate or Limited: Technical factors such as fetal position or maternal body habitus can sometimes limit the initial evaluation. In these cases, a follow-up scan is necessary. The detailed anatomic survey typically performed between 18 and 22 weeks of gestation becomes even more critical to confirm or exclude structural abnormalities.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup for an increased NT requires careful attention to detail to avoid common missteps that can affect patient care and counseling.

1. Over-reassurance from cfDNA: Do not assume a normal cell-free DNA (cfDNA) screening result negates the significance of an increased NT. While cfDNA is a highly effective screening tool for common trisomies, it does not screen for structural defects like CHD, has lower sensitivity for other aneuploidies, and does not detect the rare genetic syndromes associated with this finding. A detailed anatomic survey and fetal echo are still essential.
2. Misinterpreting the Measurement: Ensure the NT measurement was performed correctly between 11w0d and 13w6d, with a CRL between 45 mm and 84 mm, and in the proper midsagittal plane. An incorrectly obtained measurement can lead to unnecessary anxiety and workup.
3. Delaying Specialist Referral: An increased NT is a time-sensitive finding. Prompt referral for genetic counseling and to a center capable of performing a high-quality early anatomic survey and fetal echocardiogram is crucial for timely patient decision-making, particularly regarding diagnostic testing options like CVS.

If the increased NT is accompanied by other sonographic abnormalities (e.g., hydrops, absent nasal bone, structural defects), immediate escalation and referral to a maternal-fetal medicine specialist is warranted.

Related ACR Topics and Tools

For a comprehensive overview of all clinical scenarios related to first-trimester nuchal translucency evaluation, including routine screening and twin gestations, please see the parent topic hub article. This depth piece focuses only on the workup for an increased NT in a singleton pregnancy.

Additional GigHz tools can help you navigate adjacent clinical questions and standardize your imaging requests:

Frequently Asked Questions

What NT measurement is considered ‘increased’?

An increased nuchal translucency (NT) is most commonly defined as a measurement at or above the 95th percentile for a given fetal crown-rump length (CRL). Some institutions may also use an absolute cutoff, such as 3.0 mm or 3.5 mm, above which further investigation is recommended regardless of the percentile.

If cell-free DNA (cfDNA) screening is normal, is a fetal echocardiogram still necessary?

Yes. A normal cfDNA result is reassuring for common aneuploidies like Trisomy 21, but it does not evaluate fetal anatomy. An increased NT is an independent and strong risk factor for congenital heart disease and other structural anomalies, even in fetuses with normal chromosomes. Therefore, a detailed anatomic survey and a fetal echocardiogram remain essential parts of the workup.

Should I order a transvaginal ultrasound instead of a transabdominal one?

The primary evaluation, including the detailed anatomic survey and fetal echocardiogram, is typically performed transabdominally. A transvaginal ultrasound is rated ‘May be appropriate’ and can be a useful adjunct to provide higher-resolution images of specific structures if the transabdominal views are suboptimal, but it is not the primary modality for the complete examination.

What is the next step if the fetal echocardiogram and detailed anatomy scan are completely normal?

Even with normal imaging, the risk for aneuploidy and certain genetic syndromes remains elevated due to the initial increased NT finding. The patient should receive comprehensive genetic counseling and be offered definitive diagnostic testing, such as amniocentesis. If all testing is normal, the prognosis is generally very good, but continued surveillance with growth scans may be considered as a small residual risk for adverse outcomes persists.

Does this same workflow apply to a twin pregnancy?

No, this workflow is specific to singleton gestations. The evaluation of an increased NT in a twin pregnancy is more complex, especially in monochorionic twins, due to factors like shared circulation and the risk of twin-specific conditions. These scenarios are covered under different variants of the ACR Appropriateness Criteria.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026